0

100

200

300

400

500

600

700

800

900

2010 2011 2012 2013 2014 2015 2016Me

dia

n p

rice

in U

S d

oll

ars

pe

r p

ers

on

pe

r ye

ar

[TDF+FTC]+[LPV/r] [TDF+3TC]+[LPV/r] [ZDV+3TC]+[LPV/r]

[TDF+3TC]+[ATV/r]

0

50

100

150

200

250

300

350

400

2010 2011 2012 2013 2014 2015 2016

Me

dia

n p

rice

in U

S d

oll

ars

pe

r p

ers

on

pe

r ye

ar

[ZDV+3TC+NVP] [150+200+300] [TDF+FTC+EFV] [600+200+300] [TDF+3TC+EFV] [600+300+300]

Me

dia

n p

rice

in U

S d

oll

ars

pe

r p

ers

on

pe

r ye

ar

[ZDV+3TC]+[ATV/r]

HIV Country Profile: 2016

Estimated % of pregnant women living with HIV who received ARVs

for PMTCT

$

$

$

Total population (2016)

Life expectancy at birth (2015-2020)

GNI per capita, PPP (2015)

Estimated ART coveragechildren and adults

Health expenditure per capita (2014)

Health expenditure, total (% of GDP) (2014)

Maternal mortality per 100 000 live births (2015)

Trend since 2010

Human Development Index Value (2015)

0%

20%

40%

60%

80%

100%

PLHIV virally

suppressed

PLHIV receiving

ART

PLHIV diagnosed

0%

20%

40%

60%

80%

100%

PLHIV virally

suppressed

PLHIV receiving

ART

PLHIV diagnosed

0%

20%

40%

60%

80%

100%

PLHIV virally

suppressed

PLHIV receiving

ART

PLHIV diagnosed

Total fertility rate (births per woman) (2015-2020)

Number of births (thou-sands) (2015-2020)

Trend since 2010

Epidemiological HIV data Value [range]

Estimated number of people living with HIV

Estimated number of children aged 0 to 14 living with HIV

Estimated number of women (15+) living with HIV

Estimated adult (15-49) prevalence

Estimated number of deaths due to HIV

Estimated number of children dying due to HIV

Estimated number of people newly infect-ed with HIV

Estimated number of children newly infect- ed with HIV

Estimated incidence rate per 1 000 unin-fected population

Antiretroviral therapy (ART)

Reported number of people receiving ART

Estimated ART coverage

Reported number of children receiving ART

Estimated ART coverage (children, 0-14)*1

Value [range] Year

Antenatal care coverage - at least one visit (%)

Antenatal care coverage - at least four visits (%)

% of pregnant women with known HIV status

Antenatal care attendees who were tested for syphilis (%)

Antenatal care attendees who tested posi- tive for syphilis (%)

Antenatal care attendees who tested posi- tive for syphilis and who received benzathi-ne penicillin IM (%)

Reported number of pregnant women living with HIV who received antiretrovirals for PMTCT

Estimated % of pregnant women living with HIV who received antiretrovirals for PMTCT*2

% of infants born to women living with HIV receiving a virological test within two months of birth (EID)*1

Final mother-to-child transmission rate including breastfeeding period*3

Elimination of mother-to-child transmission (EMTCT) of HIV

and syphilis

World Bank UNPOP

UNPOP UNPOP

World Health Stat., WHO World Bank

UNPOP World Bank

90-90-90 progress towards 2020 targetsDemographic and socioeconomic data

Estimated number of people newly infected with HIV

Estimated number of deaths due to AIDS

UNPOP

* Tracing indicators for elimination of mother-to-child transmission. A colour scheme (green, orange, red) is used to indicate if the country is on target to meet 2020 targets: ¹90% ²95% ³Less than 5

WHO/HIV/2017.59

million US$

%

years US$

41 000 [34 000 - 48 000]

4 800 [ 4 000 - 5 600]

23 000 [ 19 000 - 28 000]

0.4% [0.4% - 0.5%]

1 900 [1 500 - 2 400]

<500 [<500 - <500]

1 100 [<1000 - 1 700]

<500 [<500 - <1000]

0.08 [0.05 - 0.11]

21 200

52% [38% - 64%]

1 200

26% [19% - 31%]

15.4 2 380

315 4.7

68 50

4.6 0.49

2 782

95%

47%

81%

29%

5%

...

1 400

55% [46% - 65%]

12% [10% - 15%]

16.6

2015

2014

2015

2016

2016

2016

2016

2016

2016

Senegal

56%

26%

0

1 000

2 000

3 000

4 000

5 000

6 000

7 000

8 000

2016201020052000 0

700

1 400

2 100

2 800

3 500

2016201020052000

55%

0%

20%

40%

60%

80%

100%

PLHIV virally suppressedPLHIV receiving ARTPLHIV diagnosed

N/A

52%

40%

Needles distributed per person who inject drugs per year 54

Percentage condom use among sex workers with most recent client 94%

HIV prevalence among men who have sex with men (%) 42%

Percentage of men reporting using a condom the last time they had anal sex with a male partner 73%

HIV Country Profile: 2016

Median annual price of ARV drug regimens for adults

Implementation of national policy on HIV self-testing (HIVST)

Treatment initiation threshold children

Treatment initiation threshold adults and adolescents

Implementation of Treat All adults and adolescents

Dolutegravir (DTG) as part of 1st line ARVs for adults and adolescents

Implementation of lifelong ART to pregnant & breastfeeding women

Implementation of national policy on viral load monitoring

Completion of HIV services cascades

Adaptation of WHO Key Population guidelines in national plans

National M&E plan or strategy for HIV

Method to de-duplicate key data (i.e. unique identifiers)

Nationally-representative quality assessment of facility-level ART data

National HIV policies and plans

0

100

200

300

400

500

600

700

800

900

2010 2011 2012 2013 2014 2015 2016Me

dia

n p

rice

in U

S d

oll

ars

pe

r p

ers

on

pe

r ye

ar

[TDF+FTC]+[LPV/r] [TDF+3TC]+[LPV/r] [ZDV+3TC]+[LPV/r]

[TDF+3TC]+[ATV/r]

0

50

100

150

200

250

300

350

400

2010 2011 2012 2013 2014 2015 2016

Me

dia

n p

rice

in U

S d

oll

ars

pe

r p

ers

on

pe

r ye

ar

[ZDV+3TC+NVP] [150+200+300] [TDF+FTC+EFV] [600+200+300] [TDF+3TC+EFV] [600+300+300]

Me

dia

n p

rice

in U

S d

oll

ars

pe

r p

ers

on

pe

r ye

ar

[ZDV+3TC]+[ATV/r]

First line Second line

Sources: Global AIDS Monitoring (UNAIDS/WHO/UNICEF), Spectrum estimates (UNAIDS/WHO) and WHO HIV Country Intelligence Tool, 2017

WHO/HIV/2017.59

* Tracing indicators for elimination of mother-to-child transmission. A colour scheme (green, orange, red) is used to indicate if the country is on target to meet 2020 targets: ¹90% ²95% ³Less than 5

WHO/HIV/2017.59

Key populations

2015

2014

2015

2016

2016

2016

2016

2016

2016

0%

20%

40%

60%

80%

100%

PLHIV virally suppressedPLHIV receiving ARTPLHIV diagnosed

0

50

100

150

200

250

300

350

2010 2011 2012 2013 2014 2015 2016

[ZDV+3TC+NVP] [150+200+300]mg [TDF+FTC+EFV] [600+200+300]mg [TDF+3TC+EFV] [600+300+300]mg

0

100

200

300

400

500

600

700

2010 2011 2012 2013 2014 2015 2016

[TDF+FTC]+[LPV/r] [TDF+3TC]+[LPV/r] [ZDV+3TC]+[LPV/r] [TDF+3TC]+[ATV/r] [ZDV+3TC]+[ATV/r]

Me

dia

n p

rice

in

US

do

lla

rs p

er

pe

rso

n p

er

ye

ar

Med

ian

pri

ce in

US

do

llars

per

per

son

per

yea

r

Senegal

Unknown

Treat All regardless of age

Treat All regardless of CD4 count

Implemented in few (<50%) treatment sites

TDF/3TC(FTC)/EFV first line ARVs only

Implemented countrywide

Partially implemented

Data not reported

Partially

Data not reported

Data not reported

Data not reported

Needles distributed per person who inject drugs per year 54

Percentage condom use among sex workers with most recent client 94%

HIV prevalence among men who have sex with men (%) 42%

Percentage of men reporting using a condom the last time they had anal sex with a male partner 73%